Pharma / Biotech

Anticoag Teams Help Optimize DOAC Monitoring



Las Vegas—A major marketing pitch for direct oral anticoagulants (DOACs) is that DOAC patients don’t require routine monitoring—one of the chief downsides of warfarin therapy.

Source link

Related posts

SUMATRIPTAN SUCCINATE Tablet, Film Coated [Mylan Pharmaceuticals Inc.]

Newsemia

KEYSTONE (Benzalkonium Chloride) Solution [Ecolab Inc.]

Newsemia

MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG Tablet, Film Coated [Novadoz Pharmaceuticals LLC]

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World